NPPA issues notices against 15 companies for introducing 22 drugs without prior approval

he National Pharmaceutical Pricing Authority (NPPA) has issued notices against 15 companies for introducing 22 drugs without prior approval. Name of the companies and the respective drugs for which notices have been issued are Alembic Pharmaceuticals Ltd for drug Resync 75/50 mg and Trivogo tablet, Biocon Limited for drug Blisto Trio 0.2/500/2 mg, BoehringerIngelheim India Pvt Ltd and Kemwell Biopharma Pvt. Ltd for drug Buscogast plus tablets, Cipla Limited for drug Hepcvel tablets, Dr. Reddys

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.001125 seconds